Fourth quarter revenue increased 12% to $59.9 billion Fourth quarter GAAP 1 operating earnings were $401 million and GAAP diluted EPS was $0.96 Fourth quarter non-GAAP operating earnings increased 14% to $605 million and non-GAAP diluted EPS increased 29% to $1.
84 Fiscal Year 2024 operating cash flow and adjusted free cash flow reached all-time highs of $3.8 billion and $3.9 billion , respectively Fiscal year 2025 non-GAAP EPS guidance raised to $7.
55 to $7.70 , from at least $7.50 DUBLIN, Ohio , Aug.
14, 2024 /PRNewswire/ -- Cardinal Health (NYSE: CAH ) today reported fourth quarter fiscal year 2024 revenues of $59.9 billion , an increase of 12% from the prior year. GAAP operating earnings were $401 million and GAAP diluted earnings per share (EPS) were $0.
96 . Non-GAAP operating earnings increased 14% to $605 million , driven primarily by segment profit increases in Global Medical Products and Distribution (GMPD) and Pharmaceutical and Specialty Solutions. Non-GAAP diluted earnings per share (EPS) increased 29% to $1.
84 in the quarter, reflecting the increase in non-GAAP operating earnings across the business, lower interest and other expense, a lower non-GAAP effective tax rate and a lower share count. Fiscal year 2024 revenues were $226.8 billion , an 11% increase from fiscal year 2023.
GAAP operating earnings were $1.2 billion and GAAP diluted EPS was $3.45 .
Non-GAAP operating earnings increased 16% to $2.4 billion , driven primarily by segment profit increases in GMPD .